Ranks 4th in the TOP-20 manufactures in terms of the hospital procurements volume. 

The annual value of the company's shipments in this segment amounted to 30.9 billion rubles (+19.2% to the value for the year 2021). The market share was 5.2%.

4 drug products manufactured by Pharmasyntez were included in the TOP-10 INN in terms of import substitution in the healthcare providers segment in the monetary values.  

Ranks 17th in the TOP-20 manufactures in the subsidized drug coverage segment.  

The total worth of shipments increased by 1.8% and amounted to 5.6 billion rubles.  

Ranks 17th in the TOP-20 manufactures in terms of sales in the Russian pharmaceutical market.

In total, six Russian pharmaceutical companies were included in the rating. Pharmasyntez occupied 1.7% market share among all pharmaceutical companies in Russia, including international ones.

The annual sales volume increased by 15.9% and amounted to 38.6 billion rubles.  

The ratings were formed by the analytical company DSM Group